as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
2.82%
Downside
1.84%
Upside
52 Week's Low
52 Week's High
74.89%
Downside
7.27%
Upside
Check Fulcrum Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$498.7M
EPS (TTM)
-1.1438
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-26.95
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-81.3M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-30.00%
Track how Fulcrum Therapeutics Inc P/E has moved over time to understand its valuation trends.
Fulcrum Therapeutics Inc in the last 5 years
Lowest (-21.64x)
June 30, 2024
Today (-26.95x)
October 27, 2025
Industry (-0.88x)
October 27, 2025
Highest (-1.63x)
June 30, 2023
Today’s Price to Earnings Ratio: -26.95x
Compare market cap, revenue, PE, and other key metrics of Fulcrum Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $498.7M | -12.02% | -26.95 | 0.00% | |
| BUY | $60.7B | 265.42% | -505.15 | -12.96% | |
| NA | $35.8B | NA | NA | -3.89% | |
| BUY | $108.0B | 98.59% | 29.95 | 31.86% | |
| BUY | $61.3B | -0.78% | 14.55 | 31.37% |
The Fulcrum Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Fulcrum Therapeutics Inc investment value today
Current value as on today
₹2,93,634
Returns
₹1,93,634
(+193.63%)
Returns from Fulcrum Therapeutics Inc Stock
₹1,89,028 (+189.03%)
Dollar Returns*
₹4,606 (+4.61%)
Based on 14 analysts
78.57%
Buy
14.29%
Hold
7.14%
Sell
Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Fulcrum Therapeutics Inc. Average target price of $12.19
Get share price movements and forecasts by analysts on Fulcrum Therapeutics Inc.
What analysts predicted
24.36%UPSIDE
Target Price
$12.19
Current Price
$9.22
Analyzed by
14 Analysts
Target
$12.19
Fulcrum Therapeutics Inc target price $12.19, a slight upside of 24.36% compared to current price of $9.22. According to 14 analysts rating.
Search interest for Fulcrum Therapeutics Inc Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:29% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, FULC has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 6 months, FULC stock has moved up by 161.2%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 759.0K → 80.0M (in $), with an average increase of 55.9% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -17.65M → -17.29M (in $), with an average increase of 2.1% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.9% return, outperforming this stock by 60.2%
| Organisation | Fulcrum Therapeutics Inc |
| Headquarters | 26 Landsdowne Street, Cambridge, MA, United States, 02139 |
| Industry | Health Technology |
| CEO | Mr. Alexander C. Sapir |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Alan A. Musso C.M.A., CPA | Chief Financial Officer |
Mr. Curtis G. Oltmans J.D. | Senior VP, Chief Legal Officer & Corporate Secretary |
Dr. Bradley E. Bernstein M.D., Ph.D. | Founder |
Dr. Tsun-Huei Lee M.D., Ph.D. | Founder |
Dr. Danny Reinberg | Founder |
Dr. Jeffrey W. Jacobs Ph.D. | Chief Scientific Officer |
Mr. Alexander C. Sapir | CEO, President & Director |
Dr. Michael R. Green | Founder |
Dr. Rudolf Jaenisch M.D., Ph.D. | Founder |
Mr. Gregory Tourangeau | Controller & Principal Accounting Officer |
Fulcrum Therapeutics Inc share price today is $9.22 as on at the close of the market. Fulcrum Therapeutics Inc share today touched a day high of $9.39 and a low of $8.96.
Fulcrum Therapeutics Inc share touched a 52 week high of $9.89 on and a 52 week low of $2.32 on . Fulcrum Therapeutics Inc stock price today i.e. is closed at $9.22,which is 6.77% down from its 52 week high and 298.27% up from its 52 week low.
Fulcrum Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Fulcrum Therapeutics Inc (FULC) shares with as little as ₹87.796 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.96 in Fulcrum Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Fulcrum Therapeutics Inc share’s latest price of $9.22 as on October 25, 2025 at 1:29 am IST, you will get 1.0846 shares of Fulcrum Therapeutics Inc. Learn more about
fractional shares .
Fulcrum Therapeutics Inc stock has given -12.02% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?